PEQLX
Price
$37.03
Change
-$0.20 (-0.54%)
Updated
Sep 20 closing price
VIVAX
Price
$67.77
Change
-$0.06 (-0.09%)
Updated
Sep 20 closing price
Ad is loading...

PEQLX vs VIVAX

Header iconPEQLX vs VIVAX Comparison
Open Charts PEQLX vs VIVAXBanner chart's image
Putnam Large Cap Value R5
Price$37.03
Change-$0.20 (-0.54%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$67.77
Change-$0.06 (-0.09%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PEQLX vs VIVAX Comparison Chart
Loading...
VS
PEQLX vs. VIVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEQLX is a StrongBuy and VIVAX is a Buy.

FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 183B vs. PEQLX (31.2B). VIVAX pays higher dividends than PEQLX: VIVAX (2.25) vs PEQLX (1.43). PEQLX was incepted earlier than VIVAX: PEQLX (12 years) vs VIVAX (32 years). PEQLX is a more actively managed with annual turnover of: 12.00 vs. VIVAX (10.00). PEQLX has a lower initial minimum investment than VIVAX: PEQLX (0) vs VIVAX (3000). PEQLX annual gain was more profitable for investors over the last year : 26.37 vs. VIVAX (23.98). PEQLX return over 5 years is better than : 58.70 vs. VIVAX (55.44).
PEQLXVIVAXPEQLX / VIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years32 years-
Gain YTD21.10516.261130%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets31.2B183B17%
Annual Yield % from dividends1.432.2564%
Returns for 1 year26.3723.98110%
Returns for 3 years26.3028.2893%
Returns for 5 years58.7055.44106%
Returns for 10 years90.55113.9579%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VSTM2.880.05
+1.94%
Verastem
DOX86.21-1.08
-1.24%
Amdocs Limited
MP13.89-0.31
-2.18%
MP Materials Corp
MLYS11.72-0.38
-3.14%
Mineralys Therapeutics
CNSP0.14-0.01
-5.36%
CNS Pharmaceuticals Inc